ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Coagulation Factor Ⅷ for Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7E8201
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Coagulation Factor Ⅷ for Injection Market Insights Forecast to 2028
BUY CHAPTERS

Global Recombinant Coagulation Factor Ⅷ for Injection Market Research Report 2025

Code: QYRE-Auto-7E8201
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novo Nordisk A S
Baxter
Bayer
GC Pharma
Shanghai Raas Corp
Hualan Biological
Shandong Taibang Biological Products
Shanghai Xinxing Medicine
SinoCell Tech

Recombinant Coagulation Factor Ⅷ for Injection Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Recombinant Coagulation Factor Ⅷ for Injection Market

Recombinant Coagulation Factor Ⅷ for Injection Market

The global market for Recombinant Coagulation Factor Ⅷ for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Recombinant Coagulation Factor VIII for Injection, This product is used in the treatment of haemophilia A with plasma coagulation factor VIII (F VIII) deficiency. It acts as a temporary substitute for the missing clotting factor in the correction or prevention of bleeding, emergency or elective surgery.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Coagulation Factor Ⅷ for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Coagulation Factor Ⅷ for Injection.
The Recombinant Coagulation Factor Ⅷ for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Coagulation Factor Ⅷ for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Coagulation Factor Ⅷ for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Coagulation Factor Ⅷ for Injection Market Report

Report Metric Details
Report Name Recombinant Coagulation Factor Ⅷ for Injection Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • 250 IU/Bottle
  • 500 IU/Bottle
  • 1000 IU/Bottle
  • 2000 IU/Bottle
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novo Nordisk A/S, Baxter, Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products, Shanghai Xinxing Medicine, SinoCell Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Coagulation Factor Ⅷ for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Coagulation Factor Ⅷ for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Coagulation Factor Ⅷ for Injection Market report?

Ans: The main players in the Recombinant Coagulation Factor Ⅷ for Injection Market are Pfizer, Novo Nordisk A/S, Baxter, Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products, Shanghai Xinxing Medicine, SinoCell Tech

What are the Application segmentation covered in the Recombinant Coagulation Factor Ⅷ for Injection Market report?

Ans: The Applications covered in the Recombinant Coagulation Factor Ⅷ for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Recombinant Coagulation Factor Ⅷ for Injection Market report?

Ans: The Types covered in the Recombinant Coagulation Factor Ⅷ for Injection Market report are 250 IU/Bottle, 500 IU/Bottle, 1000 IU/Bottle, 2000 IU/Bottle

Recommended Reports

Recombinant Coagulation Factors

Coagulation and Hemostasis Devices

Hemophilia and Adjacent Therapies

1 Recombinant Coagulation Factor Ⅷ for Injection Market Overview
1.1 Product Definition
1.2 Recombinant Coagulation Factor Ⅷ for Injection by Type
1.2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 250 IU/Bottle
1.2.3 500 IU/Bottle
1.2.4 1000 IU/Bottle
1.2.5 2000 IU/Bottle
1.3 Recombinant Coagulation Factor Ⅷ for Injection by Application
1.3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Recombinant Coagulation Factor Ⅷ for Injection Market Size Estimates and Forecasts
1.4.1 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue 2020-2031
1.4.2 Global Recombinant Coagulation Factor Ⅷ for Injection Sales 2020-2031
1.4.3 Global Recombinant Coagulation Factor Ⅷ for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Coagulation Factor Ⅷ for Injection Market Competition by Manufacturers
2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Coagulation Factor Ⅷ for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Coagulation Factor Ⅷ for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Coagulation Factor Ⅷ for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Coagulation Factor Ⅷ for Injection, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Coagulation Factor Ⅷ for Injection, Date of Enter into This Industry
2.8 Global Recombinant Coagulation Factor Ⅷ for Injection Market Competitive Situation and Trends
2.8.1 Global Recombinant Coagulation Factor Ⅷ for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Coagulation Factor Ⅷ for Injection Players Market Share by Revenue
2.8.3 Global Recombinant Coagulation Factor Ⅷ for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Coagulation Factor Ⅷ for Injection Market Scenario by Region
3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region: 2020-2031
3.2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region: 2020-2025
3.2.2 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region: 2026-2031
3.3 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region: 2020-2031
3.3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region: 2020-2025
3.3.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region: 2026-2031
3.4 North America Recombinant Coagulation Factor Ⅷ for Injection Market Facts & Figures by Country
3.4.1 North America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2031)
3.4.3 North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Coagulation Factor Ⅷ for Injection Market Facts & Figures by Country
3.5.1 Europe Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2031)
3.5.3 Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Coagulation Factor Ⅷ for Injection Market Facts & Figures by Country
3.7.1 Latin America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2020-2031)
4.1.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2020-2025)
4.1.2 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2026-2031)
4.1.3 Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2020-2031)
4.2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2020-2025)
4.2.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2026-2031)
4.2.3 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2020-2031)
5.1.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2020-2025)
5.1.2 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2026-2031)
5.1.3 Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2020-2031)
5.2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2020-2025)
5.2.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2026-2031)
5.2.3 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novo Nordisk A/S
6.2.1 Novo Nordisk A/S Company Information
6.2.2 Novo Nordisk A/S Description and Business Overview
6.2.3 Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.2.5 Novo Nordisk A/S Recent Developments/Updates
6.3 Baxter
6.3.1 Baxter Company Information
6.3.2 Baxter Description and Business Overview
6.3.3 Baxter Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.3.5 Baxter Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 GC Pharma
6.5.1 GC Pharma Company Information
6.5.2 GC Pharma Description and Business Overview
6.5.3 GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.5.5 GC Pharma Recent Developments/Updates
6.6 Shanghai Raas Corp
6.6.1 Shanghai Raas Corp Company Information
6.6.2 Shanghai Raas Corp Description and Business Overview
6.6.3 Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.6.5 Shanghai Raas Corp Recent Developments/Updates
6.7 Hualan Biological
6.7.1 Hualan Biological Company Information
6.7.2 Hualan Biological Description and Business Overview
6.7.3 Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.7.5 Hualan Biological Recent Developments/Updates
6.8 Shandong Taibang Biological Products
6.8.1 Shandong Taibang Biological Products Company Information
6.8.2 Shandong Taibang Biological Products Description and Business Overview
6.8.3 Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.8.5 Shandong Taibang Biological Products Recent Developments/Updates
6.9 Shanghai Xinxing Medicine
6.9.1 Shanghai Xinxing Medicine Company Information
6.9.2 Shanghai Xinxing Medicine Description and Business Overview
6.9.3 Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
6.10 SinoCell Tech
6.10.1 SinoCell Tech Company Information
6.10.2 SinoCell Tech Description and Business Overview
6.10.3 SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Product Portfolio
6.10.5 SinoCell Tech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Coagulation Factor Ⅷ for Injection Industry Chain Analysis
7.2 Recombinant Coagulation Factor Ⅷ for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Coagulation Factor Ⅷ for Injection Production Mode & Process Analysis
7.4 Recombinant Coagulation Factor Ⅷ for Injection Sales and Marketing
7.4.1 Recombinant Coagulation Factor Ⅷ for Injection Sales Channels
7.4.2 Recombinant Coagulation Factor Ⅷ for Injection Distributors
7.5 Recombinant Coagulation Factor Ⅷ for Injection Customer Analysis
8 Recombinant Coagulation Factor Ⅷ for Injection Market Dynamics
8.1 Recombinant Coagulation Factor Ⅷ for Injection Industry Trends
8.2 Recombinant Coagulation Factor Ⅷ for Injection Market Drivers
8.3 Recombinant Coagulation Factor Ⅷ for Injection Market Challenges
8.4 Recombinant Coagulation Factor Ⅷ for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novo Nordisk A S
Baxter
Bayer
GC Pharma
Shanghai Raas Corp
Hualan Biological
Shandong Taibang Biological Products
Shanghai Xinxing Medicine
SinoCell Tech
List of Tables
 Table 1. Global Recombinant Coagulation Factor Ⅷ for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Coagulation Factor Ⅷ for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Coagulation Factor Ⅷ for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Coagulation Factor Ⅷ for Injection Average Price (US$/Bottle) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Coagulation Factor Ⅷ for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Coagulation Factor Ⅷ for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Coagulation Factor Ⅷ for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Coagulation Factor Ⅷ for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Coagulation Factor Ⅷ for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Ⅷ for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Coagulation Factor Ⅷ for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2020-2025) & (K Bottle)
 Table 18. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2026-2031) & (K Bottle)
 Table 20. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2025) & (K Bottle)
 Table 27. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2026-2031) & (K Bottle)
 Table 28. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2025) & (K Bottle)
 Table 32. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2026-2031) & (K Bottle)
 Table 33. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2020-2025) & (K Bottle)
 Table 37. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2026-2031) & (K Bottle)
 Table 38. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2025) & (K Bottle)
 Table 42. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2026-2031) & (K Bottle)
 Table 43. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2020-2025) & (K Bottle)
 Table 47. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2026-2031) & (K Bottle)
 Table 48. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle) by Type (2020-2025)
 Table 51. Global Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle) by Type (2026-2031)
 Table 52. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Coagulation Factor Ⅷ for Injection Price (US$/Bottle) by Type (2020-2025)
 Table 59. Global Recombinant Coagulation Factor Ⅷ for Injection Price (US$/Bottle) by Type (2026-2031)
 Table 60. Global Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle) by Application (2020-2025)
 Table 61. Global Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle) by Application (2026-2031)
 Table 62. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Coagulation Factor Ⅷ for Injection Price (US$/Bottle) by Application (2020-2025)
 Table 69. Global Recombinant Coagulation Factor Ⅷ for Injection Price (US$/Bottle) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 73. Pfizer Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novo Nordisk A/S Company Information
 Table 76. Novo Nordisk A/S Description and Business Overview
 Table 77. Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 78. Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 79. Novo Nordisk A/S Recent Developments/Updates
 Table 80. Baxter Company Information
 Table 81. Baxter Description and Business Overview
 Table 82. Baxter Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 83. Baxter Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 84. Baxter Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 88. Bayer Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. GC Pharma Company Information
 Table 91. GC Pharma Description and Business Overview
 Table 92. GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 93. GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 94. GC Pharma Recent Developments/Updates
 Table 95. Shanghai Raas Corp Company Information
 Table 96. Shanghai Raas Corp Description and Business Overview
 Table 97. Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 98. Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 99. Shanghai Raas Corp Recent Developments/Updates
 Table 100. Hualan Biological Company Information
 Table 101. Hualan Biological Description and Business Overview
 Table 102. Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 103. Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 104. Hualan Biological Recent Developments/Updates
 Table 105. Shandong Taibang Biological Products Company Information
 Table 106. Shandong Taibang Biological Products Description and Business Overview
 Table 107. Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 108. Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 109. Shandong Taibang Biological Products Recent Developments/Updates
 Table 110. Shanghai Xinxing Medicine Company Information
 Table 111. Shanghai Xinxing Medicine Description and Business Overview
 Table 112. Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 113. Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 114. Shanghai Xinxing Medicine Recent Developments/Updates
 Table 115. SinoCell Tech Company Information
 Table 116. SinoCell Tech Description and Business Overview
 Table 117. SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 118. SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Product
 Table 119. SinoCell Tech Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Recombinant Coagulation Factor Ⅷ for Injection Distributors List
 Table 123. Recombinant Coagulation Factor Ⅷ for Injection Customers List
 Table 124. Recombinant Coagulation Factor Ⅷ for Injection Market Trends
 Table 125. Recombinant Coagulation Factor Ⅷ for Injection Market Drivers
 Table 126. Recombinant Coagulation Factor Ⅷ for Injection Market Challenges
 Table 127. Recombinant Coagulation Factor Ⅷ for Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Coagulation Factor Ⅷ for Injection
 Figure 2. Global Recombinant Coagulation Factor Ⅷ for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Coagulation Factor Ⅷ for Injection Market Share by Type: 2024 & 2031
 Figure 4. 250 IU/Bottle Product Picture
 Figure 5. 500 IU/Bottle Product Picture
 Figure 6. 1000 IU/Bottle Product Picture
 Figure 7. 2000 IU/Bottle Product Picture
 Figure 8. Global Recombinant Coagulation Factor Ⅷ for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Coagulation Factor Ⅷ for Injection Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Recombinant Coagulation Factor Ⅷ for Injection Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Recombinant Coagulation Factor Ⅷ for Injection Sales (2020-2031) & (K Bottle)
 Figure 16. Global Recombinant Coagulation Factor Ⅷ for Injection Average Price (US$/Bottle) & (2020-2031)
 Figure 17. Recombinant Coagulation Factor Ⅷ for Injection Report Years Considered
 Figure 18. Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Manufacturers in 2024
 Figure 19. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Recombinant Coagulation Factor Ⅷ for Injection Players: Market Share by Revenue in Recombinant Coagulation Factor Ⅷ for Injection in 2024
 Figure 21. Recombinant Coagulation Factor Ⅷ for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Recombinant Coagulation Factor Ⅷ for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2020-2031)
 Figure 24. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2020-2031)
 Figure 25. United States Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2020-2031)
 Figure 28. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region (2020-2031)
 Figure 36. China Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Recombinant Coagulation Factor Ⅷ for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Recombinant Coagulation Factor Ⅷ for Injection by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Recombinant Coagulation Factor Ⅷ for Injection by Type (2020-2031)
 Figure 57. Global Recombinant Coagulation Factor Ⅷ for Injection Price (US$/Bottle) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Recombinant Coagulation Factor Ⅷ for Injection by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Recombinant Coagulation Factor Ⅷ for Injection by Application (2020-2031)
 Figure 60. Global Recombinant Coagulation Factor Ⅷ for Injection Price (US$/Bottle) by Application (2020-2031)
 Figure 61. Recombinant Coagulation Factor Ⅷ for Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024
Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor IX Market Research Report 2025
Global Recombinant Factor Products Market Research Report 2024
Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factors Market Insights Forecast to 2030
Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cryoprecipitated Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma derived Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coagulation Factor II Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clotting Factor Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor IV Market Research Report 2024
Global Clotting Factors Ⅷ Market Insights Forecast to 2030
Global Recombinant Activated Coagulation Factor VII Market Research Report 2025
Global Recombinant Growth Factors Market Research Report 2025
Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemophilia Gene Therapy Market Research Report 2025
Global Haemophilia Treatment Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions